Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-18-000005

President and CEO gave up 11,132 shares (to pay taxes)

  • President and CEO acquired 29,337 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Luly Jay R. · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2018-02-12 Grant or award : show line 1 in the form +8,600 643,421 D
2018-02-12 Grant or award : show line 2 in the form +20,737 664,158 D
2018-02-12 Shares withheld for taxes : show line 3 in the form −11,132 $76.85 $855,439 653,026 D
Loading xslF345X03/edgar.xml…